Copyright
©The Author(s) 2017.
World J Gastroenterol. May 28, 2017; 23(20): 3702-3712
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3702
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3702
Ref. | Hospital mortality | Hospital morbidity | No. alive/total (follow-up time) |
DuBay et al[13] | 11.1% (1 of gastrointestinal bleeding and multiple organ failure) | 22.2% | 6/9 (2-33 mo) |
Malde et al[15] | 11.4% (4 of multiple organ failure) | 40.0% | 16/35 (1-140 mo) |
Azoulay et al[31] | 4.5% (1 of sepsis and multiple organ failure) | 64.0% | 11/22 (7-84 mo) |
Madariaga et al[21] | 11.0% (1 of liver failure) | 22.2% | 6/9 (3-156 mo) |
Giordano et al[25] | 4.0% (1 of liver failure) | 39.1% | 16/23 (1-33 mo) |
Hemming et al[24] | 8.3% (liver failure and multiple organ failure) | 43.0% | 46/60 (median 31 mo) |
Yamamoto[29] | 28.6% (1 of sepsis, 1 of liver failure) | 28.6% | 2/7 (2-72 mo) |
Lodge et al[10] | 25% (1 of sepsis and multiple organ failure, 1 of respiratory and renal failure) | 87.5% | 7/8 (0.5-30 mo) |
- Citation: Li W, Han J, Wu ZP, Wu H. Surgical management of liver diseases invading the hepatocaval confluence based on IH classification: The surgical guideline in our center. World J Gastroenterol 2017; 23(20): 3702-3712
- URL: https://www.wjgnet.com/1007-9327/full/v23/i20/3702.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i20.3702